We found that this subgroup of MNX1-rearranged adult AML samples have a unique mutational profile with a much higher rate of BCOR mutations (53%) than other AML samples (1%) as well as del(7q) AML (10%; ref. 11). This evidence concerns the gene BCOR and acute myeloid leukemia.